Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.05 USD | 0.00% | -1.56% | -0.79% |
Financials (USD)
Sales 2022 | 18.57M | Sales 2023 | 17.47M | Capitalization | 39.45M |
---|---|---|---|---|---|
Net income 2022 | -2M | Net income 2023 | -5M | EV / Sales 2022 | 2.91 x |
Net Debt 2022 | 6.69M | Net Debt 2023 | 15.71M | EV / Sales 2023 | 3.16 x |
P/E ratio 2022 |
-18.9
x | P/E ratio 2023 |
-6.79
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 71.37% |
Latest transcript on ImmuCell Corporation
1 week | -1.56% | ||
Current month | -4.72% | ||
1 month | +1.20% | ||
3 months | -5.61% | ||
6 months | +2.02% | ||
Current year | -0.79% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Brigham
CEO | Chief Executive Officer | 63 | 89-08-31 |
Bobbi Brockmann
BRD | Director/Board Member | 48 | 09-12-31 |
Corporate Officer/Principal | 68 | 16-04-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Brigham
CEO | Chief Executive Officer | 63 | 89-08-31 |
David Tomsche
CHM | Chairman | 67 | 06-12-20 |
Bobbi Brockmann
BRD | Director/Board Member | 48 | 09-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 5.05 | 0.00% | 2,492 |
24-04-17 | 5.05 | 0.00% | 5,926 |
24-04-16 | 5.05 | -0.39% | 20,001 |
24-04-15 | 5.07 | +1.00% | 13,136 |
24-04-12 | 5.02 | -2.15% | 3,144 |
Delayed Quote Nasdaq, April 18, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-0.79% | 39.14M | |
-1.82% | 41.35B | |
+44.25% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- ICCC Stock